gms | German Medical Science

27th German Cancer Congress Berlin 2006

German Cancer Society (Frankfurt/M.)

22. - 26.03.2006, Berlin

Cancer metastases in the spleen

Meeting Abstract

Search Medline for

  • corresponding author presenting/speaker Jörg Sauer - HELIOS Kliniken Schwerin, Deutschland
  • Klaus Dommisch - HELIOS Kliniken Schwerin, Schwerin
  • Karin Sobolewski - HELIOS Kliniken Schwerin

27. Deutscher Krebskongress. Berlin, 22.-26.03.2006. Düsseldorf, Köln: German Medical Science; 2006. DocPO412

The electronic version of this article is the complete one and can be found online at:

Published: March 20, 2006

© 2006 Sauer et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.



Introduction: Metastasis in the spleen is rare and a sign of expanded cancer disease. But it is unclear how often metastasis of an epithelial cancer arise in the spleen.

Material and method: We evaluated the documentation of the “Tumorcenter Schwerin” up to 31.12.2004 to receive the frequency of epithelial metastases in the spleen.

Results: 21 % of all 23.515 patients developed a metastasis. Only 83 patients (0.35 %) developed metastases in the spleen. The most frequent spleen-spreading cancer were endometrial cancer (4.35 %) followed by cancer of parotis (2.33 %) and anal cancer (2.08 %). 3 metastases occurred as a manifestation of a CUP-syndrome. Only 2 further patients developed an exclusively metastasis in the spleen (cancer of stomach and esophagus).

Conclusions: Epithelial cancer spread very rarely into the spleen. Only 5 patients of more than 23.000 tumor patients developed a solitaire metastasis in the spleen. In all other patients synchronous or metachronous metastases had arisen. The detection of a splenic tumor should lead to a histological clarifying of the lesion.